DARPA commercial solutions opening - embedded entrepreneur initiative
Active Definitive Contract Awarded Last action
- Contract number
- HR001126CE048
- Awardee
-
Biocircuit Technologies Inc. UEI E9KLDNMNYJK5
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $350,000
Award facts
- Opportunity
-
- DARPA's Commercial Solutions Opening (DCSO) for Commercial Strategy Solicitation · HR001125RE003 · Posted May 1, 2025
- Contract value 100% obligated
- $350,000.00 Current and potential, with all options
- Completion date 77% complete
- Current and potential, with all options
- NAICS code
- 334515 Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals
- PSC
- B541 Special Studies/Analysis- Defense
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 28 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Arlington, VA 22203, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $350,000 |
About this award
The Defense Advanced Research Projects Agency awarded a $350,000 definitive contract to Biocircuit Technologies Inc. (doing business as Axion PNI) on January 28, 2026, to commercialize DARPA-derived microneedle array technology for military and civilian applications under the Embedded Entrepreneurship Initiative, a Commercial Solutions Opening.
The originating solicitation seeks proposals from organizations possessing technology derived from prior DARPA R&D efforts to transition and commercialize innovations into practical capabilities. Evaluation criteria include potential contribution to DARPA's mission, commercialization readiness, and fair and reasonable pricing. The contract carries firm fixed-price pricing with a base performance period of 12 months and an optional Minimum Viable Product extension to 24 months, with ultimate completion targeted January 27, 2027.
Place of performance is Arlington, VA. Biocircuit's core capability centers on microneedle array and microhook-based device engineering for surgical repair and in-situ diagnostics. The company holds a prior $1.83 million Other Transaction IDV from DARPA (awarded September 2023) for the Microneedle Arrays for In-Situ Diagnosis of Electronic Systems program, which applies its tissue-interface expertise to real-time monitoring of electronic component health and failure prediction in defense systems.
Quick answers
Who was awarded contract HR001126CE048?
HR001126CE048 was awarded to Biocircuit Technologies Inc. by Defense Advanced Research Projects Agency (Department of Defense) on January 28, 2026.
How much is contract HR001126CE048 worth?
The government has obligated $350,000 on HR001126CE048.
Was contract HR001126CE048 competed?
The extent of competition for HR001126CE048 was competed under sap. The government received 28 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award